29/2021・Trifork completes strategic review of Dawn Health A/S. Upgrades 2021 EBIT guidance to EURm 34-36.5 (previously EURm 13-15.5)
November 30, 2021 11:05 ET
|
Trifork Holding AG
Company Announcement No. 29/2021Schindellegi, Switzerland - 30 November 2021 As previously communicated (latest in the Q3 2021 report on 2 November 2021), Trifork Group has conducted a strategic...